Echo Therapeutics, Inc. SEC Filings

Filed On	Filing
07 Sep 2021	REVOKED
21 Apr 2017	8-K: Other Events
06 Apr 2017	PRIMARY DOCUMENT
31 Mar 2017	PRIMARY DOCUMENT
23 Mar 2017	Form 4: Goldberg Michael M, Director Received 25,000 shares as a grant or award
23 Mar 2017	Form 4: Goldberg Shepard M, Director Received 25,000 shares as a grant or award
22 Mar 2017	Form 4: Schoenbart Alan Wayne, Director Received 100,000 shares as a grant or award · Granted 500,000 Stock Option (Right to Buy)
22 Mar 2017	Form 4: Schoenbart Alan Wayne, Director Gave up 28,000 shares to cover exercise price or tax ($9.52K)
22 Mar 2017	8-K: Departure/Election of Directors or Officers; Compensation
02 Feb 2017	8-K: Triggering Events That Accelerate a Financial Obligation
27 Dec 2016	8-K: Other Events
14 Dec 2016	8-K: Other Events
02 Dec 2016	8-K: Other Events
01 Dec 2016	8-K: Changes in Registrant's Certifying Accountant
23 Nov 2016	Form 4/A: Schoenbart Alan Wayne, INTERIM CEO, CFO AND SECRETARY Received 100,000 shares as a grant or award
23 Nov 2016	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
16 Nov 2016	FORM 10-Q
14 Nov 2016	NT 10-Q
19 Oct 2016	8-K: Creation of a Direct Financial Obligation
27 Sep 2016	8-K: Departure/Election of Directors or Officers; Compensation

Comments